CHART Thread, page-36

Really not sure what we were expecting. The share price rose dramatically in July on the speculation that GSS would show huge figures and project the share price to over $3.00. The numbers came out and were spectacular. 7 million dollars in revenue from 1 quarter, this is just the start really, covid is not going away and will still be haunting us in years to come. this is only 1 facet of all the tests that will be taking place in years to come, ie STDs, influenza, all markets which are being masked by the pandemic. Everything else is still going to be there, it is just of lower priority right now.
GSS revenue growth is now going to be exponential. The price rose on expectations that were unrealistic in such a short time frame, but the real value is only a matter of time. You cant judge a company by its share price, its up and down all the time. hang in and buy the dips, rewards come to the patient investor.
GLADYOR